semustine has been researched along with prednisone in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (90.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silberman, H; Solomon, A; Tornyos, K | 1 |
| Bartolucci, A; Dorfman, RF; Durant, JR; Gams, RA; Velez-Garcia, E | 1 |
| Bekesi, JG; Holland, JF; Roboz, JP; Zimmerman, E | 1 |
| Ahmann, DL; Bisel, HF; Eagan, RT; Edmonson, JH; Hahn, RG; Steinfeld, JL; Taylor, WF; Tormey, DC | 1 |
| Dhingra, K | 1 |
| Ahmann, DL; Bisel, HF; Edmonson, JH; Hahn, RG; Ingle, JN; Schaid, DJ | 1 |
| Chang, CH; Horton, J; Kramer, S; Nelson, JS; Perez-Tamayo, R; Salazer, O; Schoenfeld, D; Tsukada, Y; Weinstein, A | 1 |
| Curuchet, M; Dragosky, M; Garay, G; Huberman, AB; Lein, JM; Palmer, L; Pavlovsky, S; Quiroga-Micheo, E; Saslavsky, J; Tezanos Pinto, M | 1 |
| Becherini, JO; Cavagnaro, F; Jait, C; Lein, JM; Micheo, EQ; Musso, A; Pavlovsky, S; Pileggi, JE; Pizzolato, M; Suárez, A | 1 |
| Gu, YJ; Guo, X; Guo, Y; Lu, H; Ma, X; Pang, Z; Wang, B | 1 |
8 trial(s) available for semustine and prednisone
| Article | Year |
|---|---|
Phase II study of oral methyl-CCNU and prednisone in previously treated alkylating agent-resistant multiple myeloma.
Topics: Administration, Oral; Adult; Aged; Alkylating Agents; Clinical Trials as Topic; Drug Resistance; Drug Therapy, Combination; Humans; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Risk; Semustine | 1977 |
Southeastern Cancer Study Group trials with nitrosoureas in Hodgkin's disease.
Topics: Administration, Oral; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Lomustine; Nitrosourea Compounds; Prednisone; Procarbazine; Semustine; Vinblastine | 1976 |
Treatment of multiple myeloma: an Argentine Group for the Treatment of Acute Leukemia Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Argentina; Clinical Trials as Topic; Cyclophosphamide; Humans; Melphalan; Multiple Myeloma; Prednisone; Random Allocation; Semustine; Vincristine | 1988 |
The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drug.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Ifosfamide; Prednisone; Random Allocation; Semustine | 1987 |
Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
Topics: Adult; Age Factors; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Carmustine; Clinical Trials as Topic; Dacarbazine; Drug Therapy, Combination; Female; Glioma; Humans; Male; Middle Aged; Prednisone; Probability; Prognosis; Radiotherapy Dosage; Random Allocation; Semustine | 1983 |
A randomized trial of melphalan and prednisone versus melphalan, prednisone, cyclophosphamide, MeCCNU, and vincristine in untreated multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Proteins; Clinical Trials as Topic; Cyclophosphamide; Humans; Immunoglobulins; Melphalan; Multiple Myeloma; Myeloma Proteins; Neoplasm Staging; Prednisone; Random Allocation; Semustine; Time Factors; Vincristine | 1984 |
Comparison of two combination chemotherapy regimens for multiple myeloma: methyl-CCNU, cyclophosphamide, and prednisone versus melphalan and prednisone.
Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Humans; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Staging; Prednisone; Prognosis; Semustine; Time Factors | 1980 |
A randomized phase II study of CEOP with or without semustine as induction chemotherapy in patients with stage IE/IIE extranodal NK/T-cell lymphoma, nasal type in the upper aerodigestive tract.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Female; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Invasiveness; Nose Neoplasms; Pharyngeal Neoplasms; Prednisone; Prognosis; Radiation Injuries; Semustine; Survival Rate; Vincristine; Young Adult | 2009 |
2 other study(ies) available for semustine and prednisone
| Article | Year |
|---|---|
Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
Topics: AKR murine leukemia virus; Animals; Antibodies, Viral; Antigens, Neoplasm; Antineoplastic Agents; Drug Therapy, Combination; Female; Immunization; Immunotherapy; Interferons; Leukemia L1210; Leukemia, Experimental; Male; Mice; Mice, Inbred AKR; Neuraminidase; Prednisone; Ribavirin; Semustine; T-Lymphocytes; Vincristine | 1976 |
An analysis of a multiple-drug program in the treatment of patients with advanced breast cancer utilizing 5-fluorouracil, cyclophosphamide, and prednisone with or without vincristine.
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Ifosfamide; Prednisone; Semustine; Vincristine | 1975 |